

Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD). Among its major competitors, Rockwell Medical is ranked in 9th place for NPS while Abbott is 1st, and Medtronic is 2nd.Their current market cap is $108.54M